Pharmacokinetic Study of Oxidized Dextrans

A. A. Starostenko; A. V. Troitskii; V. S. Medvedev; E. P. Gulyaeva; T. N. Bystrova; V. A. Shkurupii

doi:10.1007/s11094-016-1373-6

Pharmacokinetic Study of Oxidized Dextrans

Autores: Starostenko A.A.¹, Troitskii A.V.¹, Medvedev V.S.¹, Gulyaeva E.P.¹, Bystrova T.N.¹, Shkurupii V.A.¹
Afiliações:
1. Institute of Experimental and Clinical Medicine, Siberian Branch, Russian Academy of Medical Sciences
Edição: Volume 49, Nº 12 (2016)
Páginas: 795-797
Seção: Molecular-Biological Problems of Drug Design and Mechanism of Drug Action
URL: https://ogarev-online.ru/0091-150X/article/view/244294
DOI: https://doi.org/10.1007/s11094-016-1373-6
ID: 244294

Citar

Texto integral

Acesso aberto
Acesso é fechado

Acesso está concedido
Acesso é fechado

Somente assinantes

Resumo
Sobre autores
Bibliografia
Arquivos suplementares
Estatísticas

Resumo

Methods of obtaining biotinylated oxidized dextran (BTOD) and procedures for pharmacokinetic studies of BTOD and biotinylated dextran (BTD) are described. The pharmacokinetics results showed that there are no differences in principle between the oxidized and unoxidized dextrans. All studied dextrans were characterized by two-phase pharmacokinetic profiles after intraperitoneal and subcutaneous administration.

Palavras-chave

oxidized dextran, pharmacokinetics, biotin, immunoenzymatic assay

Sobre autores

A. Starostenko

Institute of Experimental and Clinical Medicine, Siberian Branch, Russian Academy of Medical Sciences